HRT Financial’s Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 WRAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$2K 3616
2023
Q1
$2K Hold
25,000
﹤0.01% 2367
2022
Q4
$1K Buy
+25,000
New +$1.01K ﹤0.01% 2393

Other funds holding WRAC.WS

HRT Financial's WRAC.WS Position: Q2 2023 in Review

HRT Financial sold out of Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) in Q2 2023, closing a stake of 25,000 shares — an estimated $2K sold.

HRT Financial first reported a position in WRAC.WS in Q4 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2023. 8 funds tracked by Wall St. Rank hold WRAC.WS as of Q2 2023.

  • HRT Financial reported no remaining Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 25,000 Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q2 2023, an estimated $2K.
  • HRT Financial first reported a position in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in Q4 2022 and held it in 2 quarters.
  • HRT Financial's Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $2K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.